FAS-IN-1 Catalog No.:M8352-10 Saxagliptin was approved in 2008

Saxagliptin was approved in 2008 for the treatment of type 2 diabetes

InChi: InChI=1S/C23H26IN7O2S/c24-18-15-27-22(30-20(18)25-9-5-10-26-21(32)19-8-4-13-34-19)28-16-6-3-7-17(14-16)29-23(33)31-11-1-2-12-31/h3-4

InChi: InChI=1S/C20H22N4O2/c1-25-15-7-4-6-14(12-15)22-20-23-18-10-3-2-9-17(18)19(24-20)21-13-16-8-5-11-26-16/h2-4

and constipation associated with irritable bowel syndrome

is an NMDA glutamate receptor antagonist

FAS-IN-1 Catalog No.:M8352-10 Saxagliptin was approved in 2008FASN IN 4 tosylate is a potent inhibitor of fatty acid synthase (FASN) extracted from patent WO 2012064642 A1, compound 29; has an IC50 of 10 nM. Product information CAS Number: 1375105 96 6 Molecular Weight: 477. 58 Formula: C26H27N3O4S Chemical Name: 4 cyclopropyl 9 [4 (quinolin 7 yl)benzenesulfonyl] 1 oxa 4,9 diazaspiro[5. 5]undecan 3 one Smiles: O=C1COC2(CN1C1CC1)CCN(CC2)S(=O)(=O)C1C=CC(=CC=1)C1=CC2=NC=CC=C2C=C1 InChiKey: OGGOWHOQMIINAZ UHFFFAOYSA